3 Considerations for Vaccine Process Development

 3 Considerations for Vaccine Process Development

by Rachel Legmann, Director, Viral Vectors & Gene Therapy Tech, Pall Biotech and Byron Rees, Senior Manager, Scientific and Laboratory Services (SLS), Pall Biotech 

Vaccines have been around and proven as important life-saving tools since the 1790s. Yet, at the start of 2020 new development programs were lagging and there was unfounded controversy over their value.

All that swiftly changed in the spring of 2020, as the COVID-19 pandemic took hold globally. Vaccines became one of the hottest topics in industry and mainstream media practically overnight. But what does it really take to produce great vaccines?

Read more on Labcompare.